1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Novartis Patient Assistance Program is sponsored by Novartis Patient Assistance Foundation. The Novartis Patient Assistance Foundation (NPAF) provides Novartis medications free of cost to eligible patients who have limited or no prescription insurance coverage and cannot afford the cost of their medication. The program covers a wide range of Novartis-manufactured medications for various chronic and serious medical conditions.
Geographic focus: United States and US Territories
Focus areas: Healthcare, Patient Assistance, Medication Access
Get alerted about grants like this
Get emailed when new opportunities from “Novartis Patient Assistance Foundation” or related funders appear. Free, weekly, unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Novartis Patient Assistance Foundation Novartis Patient Assistance Foundation Check Eligibility Download Forms Committed to providing access to Novartis medications for those most in need Novartis is an innovative medicines company. Every day, we work to reimagine medicine to improve and extend people’s lives so that patients, health care professionals, and societies are empowered in the face of serious disease.
Novartis Patient Assistance Foundation, Inc. (NPAF) is an independent, non-profit organization which provides Novartis medications free of cost to eligible patients. To be eligible, patients must: Reside in the United States or a US Territory Be treated by a licensed US health care provider (HCP) on an outpatient basis Meet income guidelines (Alaska and Hawaii will have different income limits) Check your eligibility here .
View the full list of medications supported by the NPAF program . If you don’t see your Novartis medication listed, it isn’t supported by the NPAF program at this time. If it appears you may qualify, you and your HCP will need to complete your section of the application.
If your application is not complete, you will receive a letter with next steps. You will also receive a text message if you have opted in. You will receive a letter with the outcome of your application within 4 weeks.
Click here for details on how to obtain your medication once approved. Frequently Asked Questions I have questions about the application process How will I get my medication? What can I do if my application is denied?
Novartis Patient Assistance Foundation, Inc. (NPAF) is an independent, 501(c)(3) non-profit entity that provides certain medications at no cost to eligible patients who cannot afford the cost of their Novartis medication, are uninsured or have government insurance, and meet income guidelines and other eligibility criteria.
NPAF does not provide product to individuals having insurance associated with any type of alternate funding program that conditions, restricts, or adjusts coverage based on application to NPAF or any other free goods program. Other Terms and Conditions may apply To receive support through NPAF, applicants must submit all required documentation, including proof of income and evidence of Extra Help denial as deemed necessary.
Only the patient or their legal guardian or caregiver may enroll the patient in the program. Health plans, specialty pharmacies, pharmacy benefit managers, and their agents and representatives are prohibited from enrolling patients in the program.
Novartis Patient Assistance Foundation, Inc., at its sole and absolute discretion, reserves the right to modify or discontinue the program at any time and to verify the accuracy of enrollment information submitted. Call NPAF at 1-800-277-2254 . FAX: 1-855-817-2711 or US Mail: PO Box 2529 Columbus, OH 43216
According to the current listing, eligibility includes: Applicants must be residents of the United States or a US Territory, be treated by a licensed US healthcare provider on an outpatient basis, and meet specific income guidelines (typically between 250% and 500% of the Federal Poverty Level depending on the specific medication). Patients must have limited or no private or public prescription coverage. Confirm the full requirements in the official notice before applying.
Novartis Patient Assistance Program is funded by Novartis Patient Assistance Foundation. Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
NCI Continuing Umbrella of Research Experiences (CURE) Academic Career Excellence (ACE) Award (K32) is a grant from the National Cancer Institute (NCI) that funds early postdoctoral fellows from diverse backgrounds, including underrepresented groups, to pursue research training in cancer-related fields. The K32 award supports fellows within 12 months prior to transitioning into, or within the first two years of, a postdoctoral position. The program, operated through NCI's Center to Reduce Cancer Health Disparities (CRCHD), aims to enhance the pool of qualified diverse cancer researchers. Beginning with the June 12, 2025 due date, the CURE ACE Award is available in both Independent Clinical Trial Required and Independent Clinical Trial Not Allowed versions. Eligible applicants must be U.S. citizens or permanent residents at time of award.
NICHD Small Research Grant Program (R03 Basic Experimental Studies with Humans Required) is sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD). Supports clinical trials that prospectively assign human participants to conditions to assess biomedical or behavioral outcomes, focusing on fundamental aspects of phenomena without specific application towards processes or products in mind.
The Arkansas Economic Development Commission's FY2027 Community Assistance Grant Program is open July 1 through August 15, 2026 — $10 million total, up to $1.5 million per award, a 20% match, and eligibility that runs to cities, counties, and nonprofits. Here's how the match actually works, what the priority focus areas signal, and how to build an application that reads as a poverty-and-opportunity intervention rather than a wish list.
Read articleWhile founders chase fixed grant deadlines, the Economic Development Administration runs two flagship programs on a rolling basis — no application window, applications accepted until the money runs out. Here is how Public Works and Economic Adjustment Assistance work in FY2026, why the CEDS requirement is the real gate, and how communities should sequence an application.
Read articleHRSA's brand-new Rural Hospital Provider Assistance Program splits $24.75M among eligible rural hospitals with 50 or fewer beds and a Medicare wage index under 0.90. It's not scored competitively — every eligible hospital that applies by July 27 gets a roughly equal share. Here's how the three eligibility numbers work and why registration, not narrative, is the real risk.
Read article